Celltrion holdings Nasdaq

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, saw the amount of listed local shares it owns rise...

South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...

Celltrion Inc., South Korea's leading biosimilar maker, on Wednesday expressed its ambition to join the global top 10 biotech and pharmaceutical com...

South Korea’s entertainment powerhouse CJ ENM Co. announced on Thursday that it will hold its annual K-pop festival KCON in Hong Kong for the ...

South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...

LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...

POSCO Holdings Inc.'s Chairman Choi Jeong-woo is not among the company’s next CEO candidates, suggesting Choi will leave the company after ser...

South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...

Viva Republica Inc., the operator of South Korea’s fintech platform Toss, has revived plans to go public after pushing back its stock market d...

South Korean Kakao Pay Corp.'s takeover deal of US-based Siebert Financial Corp. has failed amid the growing legal risks surrounding top executives ...

Cho Yang-rai, honorary chairman of Hankook & Company Co., has vowed to fight MBK Partners Ltd.’s bid to take over the holding company of S...

South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...

Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...

South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...

Celltrion Healthcare Co. announced on Thursday that its autoimmune disease treatment Zymfentra (the US product name for Remsima SC) is set to be lau...

South Korea's JW Holdings corporation announced on Tuesday that it started to export the multi-nutritional liquid Winuf Central 736·1085ml to...

South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...

Corporate governance and management transparency have long been the big issues influencing the so-called Korea Discount, alongside labor strife and ...

Samsung Electronics Co., the world’s largest memory chipmaker, has divested a 0.3% stake in Dutch chip equipment manufacturer ASML Holdings N....

South Korea's P&O Chemical, a joint venture of POSCO Future M Co. and OCI Holdings Co. completed the pitch plant in Tancheon Industrial Complex,...

South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the B...

South Korea's POSCO Holdings Inc. announced on Wednesday it signed a memorandum of understanding (MOU) with Invest Alberta Corporation (IAC) in Seou...

South Korean pharmaceutical giant Celltrion Inc. logged record quarterly earnings on the strong performance of its key biosimilar products while exp...

Brompton Bicycle will pursue a greener world with sustainable clothing that is stylish but durable alongside its Korean partner The Nature Holdings ...

The South Korean government is planning to sell off a 29.3% stake in Tokyo-listed game giant Nexon Co.’s holding firm NXC Corp. via a public b...

DearU Co., a K-pop fandom platform in South Korea, announced the launch of the Japanese version of "bubble" on Tuesday. DearU bubble is a private me...

Global private equity giant KKR & Co. Inc. is expected to take over Taeyoung Industry Corp., a cash cow of South Korea’s medium-sized busi...

South Korea’s biosimilar drugmaker Celltrion group on Monday moved one step closer to the planned combination of its three major affiliates wi...

South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...